Related references
Note: Only part of the references are listed.Effect of prasugrel in patients with asthma: results of PRINA, a randomized, double-blind, placebo-controlled, cross-over study
F. Lussana et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Recommendations for the standardization of light transmission aggregometry: a consensus of the working party from the platelet physiology subcommittee of SSC/ISTH
M. Cattaneo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Comparison of different procedures to prepare platelet-rich plasma for studies of platelet aggregation by light transmission aggregometry
Eti Alessandra Femia et al.
PLATELETS (2012)
The platelet P2Y12 receptor for adenosine diphosphate: congenital and drug-induced defects
Marco Cattaneo
BLOOD (2011)
Antiplatelet effects of aspirin vary with level of P2Y12 receptor blockade supplied by either ticagrelor or prasugrel
N. S. Kirkby et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
In the presence of strong P2Y12 receptor blockade, aspirin provides little additional inhibition of platelet aggregation
P. C. J. Armstrong et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Aspirin has little additional anti-platelet effect in healthy volunteers receiving prasugrel
P. D. M. Leadbeater et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Residual cyclooxygenase-1 activity and epinephrine reduce the antiplatelet effect of aspirin in patients with acute myocardial infarction
Antonio Moscardo et al.
THROMBOSIS AND HAEMOSTASIS (2011)
New P2Y12 Inhibitors
Marco Cattaneo
CIRCULATION (2010)
Dual antiplatelet therapy in cardiovascular disease: does aspirin increase clinical risk in the presence of potent P2Y12 receptor antagonists?
Timothy D. Warner et al.
HEART (2010)
Serum Thromboxane B2 Compared to Five Other Platelet Function Tests for the Evaluation of Aspirin Effect in Stable Cardiovascular Disease
Giselle Kidson-Gerber et al.
HEART LUNG AND CIRCULATION (2010)
Reduction of platelet thromboxane A(2) production ex vivo and in vivo by clopidogrel therapy
P. C. J. Armstrong et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Antagonism of P2Y(12) reduces physiological thromboxane levels
Kamala Bhavaraju et al.
PLATELETS (2010)
Haploinsufficiency of the platelet P2Y12 gene in a family with congenital bleeding diathesis
Gessica Fontana et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor
Sailaja Paruchuri et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Light Transmission Aggregometry and ATP Release for the Diagnostic Assessment of Platelet Function
Marco Cattaneo
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2009)
Platelet aggregation studies: autologous platelet-poor plasma inhibits platelet aggregation when added to platelet-rich plasma to normalize platelet count
Marco Cattaneo et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2007)
Drug therapy -: Low-dose aspirin for the prevention of atherothrombosis
C Patrono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Antiaggregatory activity in human platelets of potent antagonists of the P2Y1 receptor
M Cattaneo et al.
BIOCHEMICAL PHARMACOLOGY (2004)
To the editor:: Adenosine diphosphate (ADP) does not induce thromboxane A2 generation in human platelets
M Cattaneo et al.
BLOOD (2002)
Platelets from a patient heterozygous for the defect of P2CYC receptors for ADP have a secretion defect despite normal thromboxane A2 production and normal granule stores -: Further evidence that some cases of platelet 'primary secretion defect' are heterozygous for a defect of P2CYC receptors
M Cattaneo et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Share Paper
